Complementary Therapy to Target LDL Cholesterol: The Role of the Ezetimibe/Simvastatin Combination

References

• [ACE] American College of EndocrinologyConsensus statement on guidelines for glycemic controlEndocr Pract20028Suppl611
   Google Scholar
• [AHA] American Heart AssociationHeart disease and stroke statistical update2002Dallas, TXAHA 2001
   Google Scholar
• [AHA] American Heart AssociationHeart disease and stroke statistics – 2004 update2004Dallas, TXAHA11 2003
   Google Scholar
• [ALLHAT] ALLHAT Officers and Coordinators for the ALLHAT Collaborative GroupThe Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)JAMA200028319677510789664
   PubMed Web of Science ®Google Scholar
• AltmannSWDavisHRZhuLNeimann-Pick C1 like 1 protein is critical for intestinal cholesterol absorptionScience20043031201414976318
   PubMed Web of Science ®Google Scholar
• BallantyneCMAbaseNYuanZDose-comparison study of the combination of ezetimibe and simvastatin (Vytorin) versus atorvastatin in patients with hypercholesterolemia: The Vytorin Versus Atorvastatin (VYVA) StudyAm Heart J20051494647315864235
   PubMed Web of Science ®Google Scholar
• BallantyneCMBlazingMAKingTREfficacy and safety of ezetimibe co-administered with simvastatin compared with atorvastatin in adults with hypercholesterolemiaAm J Cardiol20049314879415194018
   PubMed Web of Science ®Google Scholar
• BallantyneCMO'KeefeJHGottoGMOverview of dyslipidemia. dyslipidemia essentials20052ng EdPhysician Pr18
   Google Scholar
• BeckmanJACreagerMALibbyPDiabetes and atherosclerosis epidemiology, pathophysiology, and managementJAMA200228725708112020339
   PubMed Web of Science ®Google Scholar
• BrownBGBrockenbroughAZhaoXQVery intensive lipid therapy with lovastatin, niacin, and colestipol for prevention of death and myocardial infarction: a 10-year Familial Atherosclerosis Treatment Study (FATS) follow-upCirculation199898Suppl I16359665051
   PubMedGoogle Scholar
• BrownBGZhaoXQChaitASimvastatin and niacin, antioxidant vitamins, or the combination for the prevention of coronary artery diseaseN Engl J Med200134515839211757504
   PubMed Web of Science ®Google Scholar
• BuchwaldHVarcoRLMattsJPEffect of partial ileal bypass surgery on mortality and morbidity of coronary heart disease in patients with hyperlipidemia. Report of the Program on Surgical Control of the Hyperlipidemias (POSCH)N Engl J Med1990323946552205799
   PubMed Web of Science ®Google Scholar
• CannonCPBraunwaldEMcCabeCMIntensive versus moderate lipid lowering statins after acute coronary syndromes. (PROVE-IT)N Engl J Med2004380149550415007110
   PubMedGoogle Scholar
• [CDCP] Centers for Disease Control and PreventionMorbidity Weekly ReportMMWR2004534714724558
   PubMedGoogle Scholar
• ChobanianAVBakinGLBlackHRThe seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 ReportJAMA200328925607212748199
   PubMed Web of Science ®Google Scholar
• ColhounHMBetteridgeDJDurringtonPNPrimary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS); multicentre randomized placebo-controlled trialLancet20043646859615325833
   PubMed Web of Science ®Google Scholar
• de LorgerilMSalenPMartinJLMediterranean diet, traditional risk factors, and the rate of cardiovascular complication after myocardial infarction: final report of the Lyon Diet Heart StudyCirculation199999779859989963
   PubMed Web of Science ®Google Scholar
• GoldbergACSapreALinJEfficacy and safety of ezetimibe coadministration with simvastatin in patients with primary hypercholesterolemia: a randomized, double-blind, placebo-controlled trialMayo Clin Proc2004796203015132403
   PubMed Web of Science ®Google Scholar
• GrundySMCleemanJIMerzBImplications of recent clinical for the national cholesterol education program Adult Treatment Panel III guidelinesCirculation2004931935
   Google Scholar
• [HPS] Heart Protection Study Collaborative StudyMRC/BHF Heart protection study of cholesterol lowering with simvastatin in 20536 high risk individuals: a randomized placebo-controlled trialLancet200236072212114036
   PubMed Web of Science ®Google Scholar
• JonesPHDavidsonMHSteinEAComparison of the Efficacy and Safety of Rosuvastatin Versus Atorvastatin, Simvastatin, and Pravastatin Across Doses (STELLAR*) TrialAm J Cardiol2003921526012860216
   PubMed Web of Science ®Google Scholar
• KashyapMLMcGovernMEBerraKLong-term safety and efficacy of a once-daily niacin/lovastatin formulation for patients with dyslipidemiaAm J Cardiol200289672811897208
   PubMed Web of Science ®Google Scholar
• KnoppRHDujovneCALe BeautAEvaluation of the efficacy, safety, and tolerability of ezetimibe in primary hypercholesterolemia: a pooled analysis from two Phase III clinical studiesInt J Clin Proct2003573638
   PubMed Web of Science ®Google Scholar
• LaRosaJCGrundySMWatersDDThe treating to new targets investigatorsN Engl J. Med200535214253515755765
   PubMed Web of Science ®Google Scholar
• [LRC] The Lipid Research Clinics-Coronary Primary Prevention Trial InvestigatorsThe relationship of incidence of coronary heart disease to cholesterol loweringJAMA1984251351646361299
   PubMed Web of Science ®Google Scholar
• Morbidity and MortalityChart book on cardiovascular, lung, and blood diseases2002NIH
   Google Scholar
• [NCEP] National Cholesterol Education ProgramExecutive summary of the third report of the National Cholesterol Education Program (NCEP): expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (ATP III)JAMA200128524869711368702
   PubMed Web of Science ®Google Scholar
• [NHANES] National Health and Nutrition Examination SurveyThird National Health and Nutrition Examination (NHANES III 1988–1994) [online]1999 Accessed 12 May 2005. URL: http://www.cdc.gov/nchs/nhanes.htm
   Google Scholar
• PearsonTPDenkeMAMcBridePEA community-based, randomized trial of ezetimibe added to statin therapy to attain NCEP ATP III goals for LDL cholesterol in hypercholesterolemic patients: the Ezetimibe Add-on to Statin Effectiveness (EASE) trialMayo Clin Proc2005805879515887425
   PubMed Web of Science ®Google Scholar
• SagerPTCapeceRLipkaLEffects of ezetimibe coadministered with simvastatin on C-reactive protein in a large cohort of hypercholesterolemic patientsAtherosclerosis2005179361715777554
   PubMed Web of Science ®Google Scholar
• SeverPSDahlofBPoulterNRThe Anglo-Scandinavian Cardiac Outcomes Trial–Lipid Lowering Arm (ASCOT-LLA): a multicenter randomized controlled trialLancet200336111495812686036
   PubMed Web of Science ®Google Scholar
• ShepherdJBlounGJMurphyMBProspective Study of Pravastatin in the Elderly at Risk. (PROSPER)Lancet200236016233012457784
   PubMed Web of Science ®Google Scholar
• Van HeekMFarleyCComptonDSComparison of the activity and disposition of the novel cholesterol absorption inhibitor, SCH58235, and its glucuronide, SCH60663Br J Pharmocol2000129174854
   PubMed Web of Science ®Google Scholar